TrialBritish journal of clinical pharmacology2019

Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers.

Antonia Brings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.